Pharmaceuticals Trio Draw Buy Ratings Ahead of 2026 Catalysts
A trio of small-cap biotechs—X4 Pharmaceuticals, Immuneering, and Tango Therapeutics—are attracting new and renewed a...
This intro outlines the cheapest index funds for retirement accounts in 2024 and explains how to balance cost with performance and risk.
24,180 articlesA trio of small-cap biotechs—X4 Pharmaceuticals, Immuneering, and Tango Therapeutics—are attracting new and renewed a...
Investors pulled back from spot XRP ETFs this week, registering zero net inflows across seven trading sessions. XRP p...
A sudden geopolitical flare pushes crypto and traditional markets lower. This morning minute: markets tumble, testing...
Federal health officials issued a warning about misleading statements from biotech billionaire Patrick Soon-Shiong re...
A hantavirus outbreak unfolds, missing a coordinated federal response, leaving travelers and insurers scrambling for ...
A lithium-tech startup has reached unicorn status with a $1 billion valuation as demand for lithium accelerates acros...
NVIDIA has stunned investors with a dramatic dividend move and a massive buyback. This article breaks down what it me...
XRP faces a pivotal moment as regulatory clarity grows and ETF options inch closer. Analysts lay out the conditions t...
As Pure Cycle reports Q2 2026 results, investors weigh margins, guidance, and growth catalysts. This deep dive transl...
Strategy shareholders approved a plan to start semi-monthly dividends on STRC preferred stock, aiming to steady price...
The SEC has published a five-year plan prioritizing digital assets and blockchain, signaling a shift toward a formal ...
A new funding framework could let Ethereum validators redirect up to 10% of staking rewards to ecosystem projects, bu...